SLRX - Salarius Pharmaceuticals Inc
Previous close
1.72
0 0%
Share volume: 30,335
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.72
0.00
0.00%
Summary score
9%
Profitability
8%
Dept financing
3%
Liquidity
58%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-25.15%
Return on assets
-21.19%
Return on sales
-2448.55%
Return on invested capital
157.02%
Total debt ratio
14.21%
Debt ratio change over timeo
-0.97%
Current Ratio
7.84%
Quick Ratio
8.74%
Cash Position Ratio
5.32%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.46%
Return on assets
-8.93%
Return on sales
0%
Return on invested capital
-24.8%
Total debt ratio
9.92%
Debt ratio change over timeo
-1.3%
Current Ratio
5.59%
Quick Ratio
0%
Cash Position Ratio
4.06%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-8.33%
Return on assets
-7.62%
Return on sales
0%
Return on invested capital
-25.67%
Total debt ratio
10.65%
Debt ratio change over time
-1.45%
Current Ratio
5.66%
Quick Ratio
0%
Cash Position Ratio
3.89%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-108.58%
Return on assets
-106.83%
Return on sales
-1278.98%
Return on invested capital
-12.07%
Total debt ratio
-97.46%
Debt ratio change over time
-0.97%
Current Ratio
-0.03%
Quick Ratio
3.12%
Cash Position Ratio
-0.73%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SLRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -25.15% | -3.65% | 12.3% | 6.42% |
| Return on assets | -21.19% | 3.5% | 3.6% | 5.35% |
| Return on sales | -2448.55% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 157.02% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 68% | 61% |
| Total debt ratio | 14.21% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.97% | 224.03% | 6.03% | 1.46% |
| Dept financing | 4% | 50% | 19% | 8% |
| Current Ratio | 5.59% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 4.06% | 1.41% | 0.73% | 1.41% |
| Liquididy | 75% | 12% | 23% | 26% |
| Short-term ratios | SLRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.46% | -16.17% | 18.05% | 7.63% |
| Return on assets | -8.93% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | -24.8% | 6.54% | 5.97% | 19.39% |
| Profitability | 0% | 43% | 75% | 85% |
| Total debt ratio | 9.92% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -1.3% | 851.68% | 10.97% | 0.58% |
| Dept financing | 2% | 50% | 21% | 8% |
| Current Ratio | 5.59% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 4.06% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 35% | 26% | 49% |